1. SkinnyRxfrom $69/mo
Compounded- Discloses:
- Pricing visible upfront: ~$179-$229/mo
The best online compounding pharmacy for GLP-1s — and why nobody can honestly rank one
Every “top compounding pharmacy” list you will find is ranking businesses whose actual product no regulator has examined. Here is what can be checked instead — and it takes about ten minutes.
The short answer
No compounding pharmacy is FDA-approved, and none can be. The FDA approves finished drug products; it does not review compounded preparations for safety, potency, purity, or effectiveness. So a ranking of “best compounded semaglutide” is ranking marketing, not verified quality. Two things are genuinely checkable, and they are the only two worth your time: is the pharmacy a 503A or an FDA-registered 503B facility, and will your provider tell you its name at all. A provider that will not answer the second question has answered it.
503A vs 503B: the only registration difference that changes anything
503A — traditional pharmacy
- • Compounds against a prescription for one named patient.
- • Licensed by a state board of pharmacy.
- • Not required to register with the FDA.
- • Not required to follow the FDA's manufacturing-quality (CGMP) rules.
- • No federal body inspects it.
503B — outsourcing facility
- • Registers with the FDA and appears on a public register.
- • Subject to FDA inspection.
- • Must follow CGMP manufacturing-quality rules.
- • Can compound in batches without a patient-specific prescription.
- • Still not FDA-approved — inspected ≠ approved.
Neither route makes the vial an FDA-approved drug. But one of them is inspected by a federal regulator and listed publicly, and the other is not. If a provider is proud of its pharmacy, it will tell you which one it is.
The 10-minute check anyone can run
- 1Ask for the pharmacy by name — in writingMessage support before you pay: “Which compounding pharmacy fills my prescription, and is it a 503A or a 503B facility?” Keep the reply. A provider that deflects this question is the finding.
- 2If they claim 503B, confirm it on the FDA registerThe FDA publishes the list of registered outsourcing facilities. A 503B claim that does not appear on that list is not a 503B.
- 3Check the state pharmacy licenseEvery state board of pharmacy has a public license lookup. Search the pharmacy name in the state it operates from and confirm the license is active and unrestricted — disciplinary actions show up here.
- 4Ask what they compound and whySince the FDA declared the semaglutide and tirzepatide shortages resolved, routine compounded copies of the brand drugs no longer sit in the shortage carve-out. A legitimate answer names a clinical reason specific to you — a dose or formulation the commercial product does not offer. “It is cheaper” is not that reason.
What each compounded-GLP-1 provider we track actually discloses
Ranked by disclosure, not by what they pay us: providers that publish their pricing, name their clinicians, and state their regulatory status up front rank above those that do not. Prices are the advertised starting price and change often — confirm on the provider's own site.
2. Edenfrom $99/mo
Compounded- Gap:
- Compounded model not disclosed upfront
3. CallOnDocfrom $199/mo
Compounded- Gap:
- Pricing fully hidden
Sponsored link — GLP1Zoom may earn a commission if you sign up, at no extra cost to you. It never affects our editorial ranking.
Before you compare prices, understand what you are buying
Compounded semaglutide and tirzepatide are not FDA-approved products. They were never in the trials the brand drugs were tested in, so the familiar efficacy figures — roughly 15% average body-weight loss on semaglutide in STEP-1, roughly 22% on tirzepatide in SURMOUNT-1 — describe the brand product, not the compounded one. The FDA does not review compounded drugs for potency, purity, or effectiveness, which means neither the result nor the contents of the vial carry a federal guarantee. That is not an argument that compounded is worthless; it is an argument for knowing exactly what is and is not standing behind it before you buy.
Read next: what changed after the FDA declared the shortages resolved · compounded semaglutide, in detail
Frequently asked questions
Which online compounding pharmacy is FDA-approved?
None, and any that claims to be is misrepresenting itself. The FDA approves finished drug products; it does not approve compounded preparations, and it does not review them for safety, effectiveness, potency, or purity. A compounding pharmacy can be legitimately licensed and still produce a product the FDA has never evaluated. What you can verify is the pharmacy's registration category and its state license — not an FDA approval that does not exist for this class of product.
What is the difference between a 503A and a 503B pharmacy?
A 503A pharmacy compounds for an individual patient against a specific prescription. It is licensed by its state board of pharmacy and is not required to register with the FDA or follow the FDA's manufacturing-quality (CGMP) rules. A 503B outsourcing facility registers with the FDA, is subject to FDA inspection, and must follow CGMP — it can compound in larger batches without a patient-specific prescription. Neither route means the product is FDA-approved. But a 503B facility is inspected by the FDA and appears on a public FDA register, which is a stronger, checkable signal than a 503A pharmacy that no federal body inspects.
How do I find out which pharmacy my telehealth provider actually uses?
Ask, in writing, before you pay: "Which compounding pharmacy fills my prescription, and is it a 503A or a 503B facility?" A provider that will not name it is telling you something. Once you have the name, you can check its license on the state board of pharmacy website for the state it operates in, and — if they claim 503B — confirm it appears on the FDA's published list of registered outsourcing facilities.
Is compounded semaglutide still legal after the shortage ended?
The FDA declared the semaglutide and tirzepatide shortages resolved, which removed the flexibility that let compounders mass-produce copies of the brand drugs during the shortage. Compounding is still lawful where it is genuinely patient-specific and clinically justified — for example a documented need for a dose or formulation the commercial product does not provide — but "compounded because it is cheaper" is not, on its own, that justification. Providers still selling routine compounded copies are operating in a space the FDA has explicitly narrowed. Ask your provider on what basis they compound for you.
Does a cheaper compounded price mean a worse product?
Price tells you nothing about potency or sterility, in either direction — and that is exactly the problem. With an FDA-approved product, the label is the guarantee. With a compounded one, there is no federal review standing behind the vial, so the price is not evidence of quality and neither is the marketing. The verifiable facts are the pharmacy's registration category, its state license status, and whether the provider will tell you either one.
Neutral comparator. We run no clinic and never sell medication — we earn the same commission whoever you pick, so this ranking is editorial, not pay-to-rank. Methodology · How we make money